SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-034263
Filing Date
2017-02-08
Accepted
2017-02-08 12:37:33
Documents
93
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d313912d10q.htm 10-Q 549828
2 EX-10.1 d313912dex101.htm EX-10.1 768295
3 EX-31.1 d313912dex311.htm EX-31.1 8670
4 EX-31.2 d313912dex312.htm EX-31.2 8884
5 EX-32.1 d313912dex321.htm EX-32.1 3953
12 GRAPHIC g313912g0205091142752.jpg GRAPHIC 2771
  Complete submission text file 0001193125-17-034263.txt   5398584

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mygn-20161231.xml EX-101.INS 895798
7 XBRL TAXONOMY EXTENSION SCHEMA mygn-20161231.xsd EX-101.SCH 56771
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20161231_cal.xml EX-101.CAL 101207
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20161231_def.xml EX-101.DEF 172909
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20161231_lab.xml EX-101.LAB 449199
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20161231_pre.xml EX-101.PRE 332416
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 17581663
SIC: 2835 In Vitro & In Vivo Diagnostic Substances